Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 24 to 28, 2022. This …
ALA Report Cites Progress Made in Reducing Tobacco Use
E-cigarette use reported by more than 2 million middle and high school students in 2021; considerable disparities reported in smoking
Three mRNA Vaccine Doses Protective Against Delta, Omicron
However, odds ratios were higher for omicron suggesting that booster doses are less protective than against delta